Therapeutic Advances and New Directions for Triple-Negative Breast Cancer

Breast Care - Switzerland
doi 10.1159/000455821
Full Text
Abstract

Available in full text

Categories
SurgeryOncology
Date
Authors
Publisher

S. Karger AG

Related search

Therapeutic Landscape in Mutational Triple Negative Breast Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Identification of Novel Therapeutic Targets for Triple-Negative Breast Cancer

2012English

Identification of New Candidate Therapeutic Target Genes in Triple-Negative Breast Cancer

Genes and Cancer
Cancer ResearchGenetics
2012English

Advances in Small-Molecule Drug Discovery for Triple-Negative Breast Cancer

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2015English

Triple-Negative Breast Cancer

2018English

Identification of New Prognostic Biomarkers for Triple Negative Breast Cancer

English

7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy

Pathology
Forensic MedicinePathology
2020English

Triple-Negative (Basal-Like) Breast Cancer: A New Entity

Breast Cancer Research
Cancer ResearchOncology
2007English

Targeted Nanoparticles for Image-Guided Treatment of Triple-Negative Breast Cancer: Clinical Significance and Technological Advances

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
MedicineBioengineeringNanotechnologyBiomedical EngineeringNanoscience
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy